期刊文献+

活血化瘀中药对大鼠实验性子宫内膜异位症异位内膜VEGF的作用 被引量:7

Studies of VEGF in Ectopic Endometrium on Luoshineiyifang on Endometriosis Model Rat
下载PDF
导出
摘要 目的:探讨活血化瘀中药罗氏内异方对大鼠实验性子宫内膜异位症的异位内膜VEGF的影响。方法:使用大鼠自体移植子宫内膜建立实验性子宫内膜异位症的模型,在造模后给以不同处理措施,采用免疫组织学SP法检测在位和异位内膜VEGF染色强度情况。结果:具有活血化瘀作用的罗氏内异方能够降低大鼠子宫内膜异位症模型异位内膜腺上皮VEGF染色指数。结论:罗氏内异方能够减少VEGF的染色强度,推测这可能是活血化瘀方法治疗子宫内膜异位症的机理之一。 Objective :To study VEGF on ectopic endometrium in endometriosis(EMT) model rat treated by Luoshineiyifang in principled by promoting blood circulation by removing blood stasis. Methods :EMT rat model were established by endometrium autotransplantion, treated by different methods. The VEGF were observed on eutotic and ectopic endometrium by histoimmunity SP. Results : Luoshineiyifang can decrease the staining index of VEGF in ectopic endometrium of EMT rat model. Conclusion : Luoshineiyifang can decrease the staining index of VEGF, maybe this is one of the mechanisms of the Herble medicine of promoting blood circulation by removing blood stasis
出处 《中医药学刊》 2006年第9期1725-1727,共3页 Study Journal of Traditional Chinese Medicine
关键词 子宫内膜异位症 疾病模型 动物 血管上皮生长因子 罗氏内异方 endometriosis disease models, animal vascular endothelial growth factor Luoshineiyifang
  • 相关文献

参考文献9

二级参考文献25

  • 1韩冰,李同玺,常暖,孙文墅.活血化瘀、软坚散结法治疗子宫内膜异位症药效学研究[J].中国医药学报,1995,10(4):4-6. 被引量:9
  • 2王俊玲.罗氏内异方治疗子宫内膜异位症的临床研究[J].广州中医药大学学报,1996,13(1):9-12. 被引量:6
  • 3Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor(VEGF) and its receptors. FASEB J, 1999, 13:9-22
  • 4Toyoaki M, Jeffrey R, Horowitz BS, et al. Vascular endothelial growth factor/Vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation, 1998, 97: 99-107
  • 5Michael O, Mueller MD, Dan I, et al. Neutrophils infiltrating the endometrium express vascular endothelial growth factor:potential role in endometrial angiogenesis. Fertil Steril, 2000, 74:107-112
  • 6Gargett CE, Rogers PA. Human endometrial angiogenesis. Reproduction, 2001, 121(2):181-186
  • 7Li XF, Charnock-Jones DS, Zhang E, et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab, 2001, 86(4):1823-1834
  • 8Charnock-Jones DS, Sharkey AM, Rajput-Williams J, et al. Identification and location of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod, 1993, 48:1120-1128
  • 9Shifren JL, Tseng JF, Zaloudek C J, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab, 1996, 81: 3112-3117
  • 10Sugino N, Kashida S, Karube-Harada A, et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction, 2002,23: 379-387

共引文献126

同被引文献127

引证文献7

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部